Researchers at SMU's Center for Drug Discovery, Design and Delivery (CD4) have succeeded in lab testing the use of chemotherapy with a specific protein inhibitor so that the chemotherapeutic is better absorbed by drug-resistant cancer cells without harming healthy cells. The approach could pave the way for a more effective way to treat cancers that are resistant to treatment.
* This article was originally published here
Sunday, 9 June 2019
New computer attack mimics user's keystroke characteristics and evades detection
Ben-Gurion University of the Negev (BGU) cyber security researchers have developed a new attack called Malboard. Malboard evades several detection products that are intended to continuously verify the user's identity based on personalized keystroke characteristics.
* This article was originally published here
* This article was originally published here
Job demands, burnout tied to weight gain
(HealthDay)—Employees with heavier workloads or who are burned out are more likely to emotionally eat and exercise less, according to a study published online May 30 in the Journal of Health Psychology.
* This article was originally published here
* This article was originally published here
Researchers find ways to hackproof smart meters
Smart electricity meters are useful because they allow energy utilities to efficiently track energy use and allocate energy production. But because they're connected to a grid, they can also serve as back doors for malicious hackers.
* This article was originally published here
* This article was originally published here
FDA targets vaping 'influencers' for online promotions
U.S. regulators moved to discipline vaping companies for inappropriately promoting their flavored nicotine formulas through so-called influencers on Facebook, Twitter and other social media sites.
* This article was originally published here
* This article was originally published here
Long-term islet transplant recipients show near-normal glucose control
Continuous glucose monitoring (CGM) evaluations in islet transplant recipients who have been insulin independent for an average of 10 years show near-normal glycemic profiles and time-in-range metrics, according to data presented by the Diabetes Research Institute at the University of Miami Miller School of Medicine. The findings, which were accepted as a late-breaking poster at the American Diabetes Association (ADA) 79th Scientific Sessions, June 7-11, 2019 in San Francisco, CA, demonstrate that islet transplantation can be a successful long-term cell therapy for select patients with type 1 diabetes.
* This article was originally published here
* This article was originally published here
Pressure mounts on aviation industry over climate change
Under pressure from frequent flyers alarmed over climate change, the airline industry says it is "hellbent" on reducing emissions—but the technology needed to drastically reduce its carbon footprint is still out of reach.
* This article was originally published here
* This article was originally published here
Subscribe to:
Posts (Atom)